SOLVAY PHARMACEUTICALS

solvay-pharmaceuticals-logo

Solvay Pharmaceuticals B.V. operates as a pharmaceutical and drugs company. The company is based in Weesp, the Netherlands. Solvay Pharmaceuticals operated as a subsidiary of [Solvay SA](/organization/solvay) until it was acquired by [Abbott Labs](/organization/abbott) in 2009.

#People #Website #More

SOLVAY PHARMACEUTICALS

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
1863-01-01

Address:
Marietta, Georgia, United States

Country:
United States

Website Url:
http://www.abbottgrowth.com

Total Employee:
11+

Status:
Closed


Current Employees Featured

thom-rowland_image

Thom Rowland
Thom Rowland Vice President of Sales and Marketing @ Solvay Pharmaceuticals
Vice President of Sales and Marketing

ed-schutter_image

Ed Schutter
Ed Schutter VP of Global Business development @ Solvay Pharmaceuticals
VP of Global Business development

Founder


ernest-solvay_image

Ernest Solvay

Official Site Inspections

http://www.abbottgrowth.com

  • Host name: e24.abbott.com
  • IP address: 130.36.62.14
  • Location: United States
  • Latitude: 41.8483
  • Longitude: -87.6517
  • Timezone: America/Chicago

Loading ...

More informations about "Solvay Pharmaceuticals"

Base Business Strength Accelerates Abbottโ€™s Growth

Jan 9, 2024 Rx Only. Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and โ€ฆSee details»

2023 ANNUAL REPORT - Abbott

Organization. We know how to meet such situations because weโ€™ve done so time and again, and weโ€™ve built the company accordingly for long-term durability. Financial Performance of COVID โ€ฆSee details»

Abbott Q3 Continues Underlying Base Business Growth | Abbott โ€ฆ

Oct 18, 2023 Abbottโ€™s underlying base business maintained its upward trajectory during the third quarter, with double-digit organic growth 1, excluding COVID-19 testing-related sales, in each โ€ฆSee details»

Abbott Q2: Strong Base Business Growth Continues

Jul 18, 2024 Abbottโ€™s financial results in the second quarter of 2024 highlight the continued strength of the companyโ€™s underlying base business 1, led by double-digit growth in Medical โ€ฆSee details»

SUMMARY REPORT GLOBAL SUSTAINABIL - my.abbott

ABOUT PROGRESS AGAINST OUR 2030 SUSTAINABILITY PLAN INNOVATE FOR ACCESS AND AFFORDABILITY Central to our goal of helping 3 billion people each year by 2030 is our โ€ฆSee details»

Abbott Growth Partners

Ready to Fund Your Needs!See details»

News Release Abbott Reports Third-Quarter 2023 Results and โ€ฆ

Established Pharmaceuticals Third Quarter 2023 Results (3Q23) Sales 3Q23 ($ in millions) Total Key Emerging Markets Other U.S. โ€” โ€” โ€” International 1,368 987 381See details»

Exhibit 99.1 News Release Abbott Reports First-Quarter 2023 โ€ฆ

Executive officer, Abbott. "Growth in our underlying base businesses accelerated, including particularly strong results in Medical Devices, Established Pharmaceuticals and Nutrition."-- โ€ฆSee details»

Building for Sustainable Growth | Abbott Newsroom

Oct 8, 2018 Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain โ€ฆSee details»

Org Chart Abbott - The Official Board

Organizational Chart of Abbott. Abbott www.abbott.com. has 166 executives and 24 subsidiaries +1 847 937 6100; Add an executive. Abbott (ABT) News . Anything missing? We search for โ€ฆSee details»

Abbott Laboratories - statistics and facts | Statista

Nov 4, 2024 Annual car sales worldwide 2010-2023, with a forecast for 2024; Monthly container freight rate index worldwide 2023-2024; Automotive manufacturers' estimated market share in โ€ฆSee details»

What Is Driving Growth For Abbott Stock? | Nasdaq

Mar 21, 2023 After a 10% fall year-to-date, at the current levels, Abbott stock (NYSE: ABT) has room for growth, in our view. ABT stock fell from $110 in early January to $99 now. The YTD โ€ฆSee details»

abbottsus.com

2025 Copyright. All Rights Reserved. Privacy PolicySee details»

Abbott Q1 Earnings: Strong Growth, Solid Start

Apr 20, 2021 The first quarter is a wrap and Abbott is off to a very good start with strong growth across all four of the company's major businesses. This growth translated to worldwide sales โ€ฆSee details»

When Established Companies Choose to Evolve for ... - The โ€ฆ

Jan 3, 2017 Her company, Invati Consulting, champions what she calls โ€œtalent driven organization designโ€ to modernize the workplace through speaking, training, and consulting โ€ฆSee details»

Lord Abbett Growth Opportunities A LMGAX - Morningstar

Oct 31, 2024 LMGAX - Lord Abbett Growth Opportunities A - Review the LMGAX stock price, growth, performance, sustainability and more to help you make the best investments.See details»

Strategy and Strength | Abbott U.S.

A Fortune 500 company. An S&P Dividend Aristocrat. Breadth and diversity make Abbott well-positioned for the future for both consumers and investors.See details»

Pediatric Growth Charts | Abbott Nutrition Canada

WHO Growth Charts FOR CANADA. The WHO Growth Charts for Canada are recommended by the Canadian Paediatric Society, Canadian Pediatric Endocrine Group, College of Family โ€ฆSee details»

Going From Strong to Stronger in 2021 | Abbott Newsroom

Jan 12, 2021 Amidst a challenging 2020, Abbott remained strong and resilient thanks to the company's diversified portfolio of life-changing products.. As 2021 kicks-off, Abbott President โ€ฆSee details»

Stronger, More Balanced, Better Than Ever | Abbott Newsroom

Jan 21, 2020 FreeStyle Libre and FreeStyle Libre 14 day Flash Glucose Monitoring systems are continuous glucose monitoring (CGM) devices indicated for replacing blood glucose testing โ€ฆSee details»